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• Hypothyroidism induced by methimazole triggered a depressive-like behavior in rats.
• Hypothyroidism also elicited cerebral stress oxidative responses.
• Dietary diphenyl diselenide was able to counteract these effects of hypothyroidism.
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Oxidative stressHypothyroidism has been associated to psychiatric disorder development and tissue oxidative damage. In this
study, we evaluated the effect of diphenyl diselenide supplementation on depressive-like behavior triggered
by methimazole exposure in female rats. Additionally, thiobarbituric acid reactive substances (TBARS), reactive
oxygen species (ROS) and non-protein thiol (NP-SH) levels were analyzed in cerebral cortex, hippocampus
and striatum structures of rats. Monoamine oxidase (MAO) activity was evaluated in total brain. Firstly, female
rats received methimazole (MTZ) 20 mg/100 ml in the drinking water for 30 days and were evaluated in
open-ﬁeld and forced swimming tests (FST). In this set of experiments, the rats exposed to MTZ presented a
depressive-like behavior, which was evidenced by a signiﬁcant increase in the immobility time when compared
to control group. Thereafter,MTZ-induced hypothyroid rats received either a standard or a diet containing 5 ppm
of diphenyl diselenide, and then they were evaluated monthly in open-ﬁeld and FST tests during 3 months. No
alteration on the locomotor performancewas observed among the groups. The depressive-like behavior of hypo-
thyroid rats was blunted by diphenyl diselenide supplementation during all experimental periods. The levels of
thyroid hormones remained low in MTZ exposed groups until the end of experimental period. The MTZ group
had an increase in TBARS and ROS levels that were restored by diphenyl diselenide supplementation. NP-SH con-
tent of cerebral structures was not modiﬁed by MTZ exposure and/or diphenyl diselenide supplementation.
Diphenyl diselenide supplementation restored theMAOB activity thatwas decreased inMTZ group. In summary,
our results show that hypothyroidism induced byMTZmethimazole triggers a depressive-like behavior in female
rats and that dietary diphenyl diselenide was able to reduce this effect.
© 2013 Elsevier Inc. All rights reserved.1. Introduction
Depression is a common and chronic illness characterized by some
neurological symptoms such as depressedmood, anhedonia, irritability,
difﬁculties in concentrating, and abnormalities in appetite and sleep [1].
In addition, depressed patients can present high rates of suicide behav-
ior and are more susceptible in developing coronary artery disease and, Universidade Federal de Santa
0 8140; fax:+55 55 3220 8240.
osa).
ghts reserved.type 2 diabetes [2]. It is well established that the incidence, prevalence
and morbidity risk of depression are greater in women than in men.
Although, the underlying mechanisms of these gender differences are
relatively unknown, there is evidence that the contribution of speciﬁc
genes and gonadal hormones to depression-like behavior occurrence
may differ between males and females [3–5,8]. Unfortunately the ofﬁ-
cial diagnosis of depression is subjective and usually based on a docu-
mentation of a certain number of symptoms, which difﬁcult the
diagnosis and knowledge of action mechanisms of disease [1,6].
Evidence from literature demonstrates that thyroid dysfunction
affects mainly women and may be linked to psychiatric disorders
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hormones increase the risk for depression development remain to be
established. Interestingly, it has been shown that thyroid hormones
accelerate and improve the therapeutic response to tricyclic antidepres-
sants and selective serotonin reuptake inhibitors in depressive patients
[11,12]. Moreover, thyroid hormone treatment improves antidepres-
sant pharmacotherapy even in patients with euthyroid hormonal state
[13].
Hypothyroidism is a clinical condition characterized by elevated
levels of the thyroid stimulating hormone (TSH) or by low levels of
triiodothyronine (T3) and thyroxin (T4). The role of thyroid hormones
on the development and functions of the central nervous system
is well established [14,15]. The lack of thyroid hormones affects neuro-
nal differentiation, migration, myelination, synaptogenesis, dendritic
branching and plasticity processes [16–18]. Considering the impact of
thyroid disease in people's health, the American Thyroid Association
recommends that adults be screened for thyroid dysfunction by mea-
surement of the serum TSH concentration, beginning at age 35 years
and every 5 years thereafter [19,20].
Regarding therapeutic strategies on experimental depression,
recently it has been demonstrated that diphenyl diselenide, a
simple organoselenium compound, exhibits potent anxiolytic and
antidepressant-like effects, which are related to central monoaminergic
and serotoninergic systems and L-arginine/NO/cGMP pathwaymodula-
tion [21–23]. In analogy, the antidepressant-like action of diphenyl
diselenide was proven inmalathion-exposed rats [24]. Indeed, diphenyl
diselenide exhibits antioxidant and neuroprotective properties, which
are closely related to its efﬁcient mimetic activities of the enzymes glu-
tathione peroxidase and thioredoxin reductase [25–29]. Taken together,
the pharmacological properties of diphenyl diselenide could be interest-
ing to verify under hypothyroidism condition, since it is linked to oxida-
tive stress and neurological disturbances like cognitive deﬁcits and
depressive behavior [30–39]. Besides, our group recently demonstrated
that the intake of diets supplemented with diphenyl diselenide im-
proves spatial learning and memory deﬁcits in hypothyroid rats [40].
In view of these considerations, this study was designed to examine
whether the depressive-like behavior induced by methimazole expo-
sure in adult female rats could be attenuated by dietary diphenyl
diselenide. Additionally, we investigated the activity of monoamine
oxidase (MAO) (E.C. 1.4.3.4) and some parameters of oxidative stress
in the cerebral cortex, hippocampus and striatum of rats.2. Materials and methods
2.1. Animals and reagents
Forty-eight adult female Wistar rats (≈200 g) purchased from our
own breeding colonywere acclimated for 10 days before the beginning
of the experiments. The animals were housed in plastic cages andmain-
tained at 22–24°°C, on a 12 h light/12 h dark cycle, with free access to
food (Supra®, Brazil) and water. All experiments were performed in
accordancewith guidelines of the Committee on Care and Use of Exper-
imental Animal Resources, Federal University of Santa Maria, Santa
Maria, RS, Brazil. Methimazole was purchased from Sigma Chemical
Co. (St. Louis,Mo, USA). Diphenyl diselenide (Fig. 1)was synthesized ac-
cording to literaturemethods [41]. Analysis of the 1H NMR and 13C NMR
spectra showed analytical and spectroscopic data in full agreementwith
its assigned structure. All other reagents were of analytical grade and
obtained from standard commercial suppliers.Fig. 1. Diphenyl diselenide structure.2.2. Experimental protocol
2.2.1. Induction of hypothyroidism
Hypothyroidismwas induced by the administration of methimazole
(MTZ) 0.02 g/100 ml, in the drinking water, as previously described by
Dias et al. [40]. Initially, female ratswere separated into two experimen-
tal groups (n = 48): control group, which receivedwater and commer-
cial food, and MTZ group, which received the solution of MTZ and
commercial food. MTZ exposure via drinking water was maintained
for 30 days and, after this period both groups were evaluated in open-
ﬁeld and forced swimming tests.
2.2.2. Diphenyl diselenide supplementation
7 days after the experimental testing cited above, the female rats
were randomly re-divided into 4 groups (n = 12): (1) control; (2)
methimazole (MTZ); (3) diphenyl diselenide (Se) and (4) diphenyl
diselenide plus methimazole (Se + MTZ). Control and MTZ groups
were supplied with a standard diet, whereas Se and Se + MTZ groups
received a diet supplemented with diphenyl diselenide at 5 ppm,
which provided approximately 5 μg selenium/g of diet/per day
(≈0.3 mg/kg body weight). The choice of this concentration was
based in previous studies from our research group indicating that
chronic dietary diphenyl diselenide did not cause toxic effects in rats
[40,42,43]. The food was prepared in an industrial mixer to allow the
uniformity of the mixture, and the diphenyl diselenide was dissolved
in soybean oil. After preparation, the diets were frozen (4 °C) and
offered ad libitum to the animals. The treatments were maintained
concomitantly for three months. The behavioral assessments were per-
formed monthly.
2.3. Behavioral testing
Open-ﬁeld and forced swimming testswere performedmonthly and
conducted between 8:00 a.m. and 2:00 p.m.
2.3.1. Open-ﬁeld test
Locomotor and exploratory activities were evaluated by open-ﬁeld
test before forced swimming test. This task was performed in a circular
apparatus (56 cm diameter) with the surface divided into 10 areas of
equal size. The rats were gently placed at the center of the apparatus
and observed for 5 min to record the locomotor (number of segments
crossed) and exploratory activities (expressed by the number of time
rearing on the hind limbs). The apparatus was cleaned between assess-
ments with a 20% ethanol solution.
2.3.2. Forced swimming test (FST)
FST was conducted using the method of Porsolt et al. [44]. Test was
carried out over 2 days; where the ﬁrst day was designed for pre-
training and the second day for test session. Brieﬂy, in the pre-training
session the rats were individually placed for 15 min in open cylinders
(45 cm height × 20 cm diameter) containing water, maintained at
25 ± 1 °C. The rats were then dried and heated by a lamp and returned
to their cages. Twenty-four hours later, rats were placed again in the
apparatus and the duration of immobility was recorded for 5 min.
Each rat was recorded as immobile when ﬂoatingmotionless or making
only those movements necessary to keep its head above water.
2.4. Tissue preparation
At the end of the experimental period, the animals were euthanized
and thewhole blood collected by cardiac puncture for themeasurement
of total thyroid hormone (tT3 and tT4) levels. Heparinized blood was
centrifuged at 3500 rpm for 5 min.
Brain was quickly removed, placed on ice and some dissected in the
hippocampus, striatumand cerebral cortex. Cerebral structures and total
brain were homogenized in cold 10 mMTris–HCl pH 7.4. Homogenates
Table 1
Plasma tT3 and tT4 levels.
Control MTZ Se MTZ + Se
tT3 0.68 ± 0.05 0.29 ± 0.03⁎ 0.58 ± 0.05 0.48 ± 0.03⁎
tT4 3.01 ± 0.25 0.53 ± 0.17⁎ 1.90 ± 0.39⁎ 1.47 ± 0.20⁎
tT3 is expressed as ng/ml plasma and tT4 as pg/ml plasma. Values are expressed as
means ± S.E.M. (5–8 rats/group).
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natant fractions (S1) for lipid peroxidation, reactive oxygen species
(ROS) and non-protein thiol (NP-SH) level determination. Monoamine
oxidase (MAO) activity was assayed in mitochondrial preparation
from total brain obtained by differential centrifugation [24]. Protein con-
centration was measured by the method of Bradford, using bovine
serum albumin as the standard [45].⁎ Denoted p b 0.05 from control group (two-way ANOVA followed Duncan's Test).2.5. Thyroid hormones determination
Plasma levels of total T4 and total T3weremeasured bymicropar-
ticle enzyme immunoassay (MEIA) using AxSYM® system (Abbott
Laboratories, Abbott Park, Illinois, USA), according to supplier's
instructions.2.6. Lipid peroxidation, ROS and NP-SH determination
Lipid peroxidation was performed by measuring thiobarbituric acid
reactive substance (TBARS) levels, according to the method of Ohkawa
et al. [46]. Brieﬂy, aliquots of the supernatant fractions from cerebral
structures were incubated at 100 °C for 1 h in acid medium containing
200 μl of 8.1% sodium dodecyl sulfate, 500 μl of 500 mM acetic acid
buffer pH 3.4 and 500 μl of 0.6% thiobarbituric acid (TBA). TBARS levels
were measured at 532 nm and the absorbance was compared with the
standard curve using malondialdehyde (MDA). Results were expressed
as nmol malondialdehyde/mg of protein.
ROS determination was based on the deacetylation of the 2′, 7′-
dichloroﬂuorescein diacetate (DCFH-DA) and its subsequent oxidation
by intracellular reactive species to DCF, a ﬂuorescent compound [47].
The supernatant fractions (S1) from cerebral structures were added to
a medium with 10 mM Tris–HCl pH 7.4 and 1 mM DCFH-DA. Incuba-
tionwas performed for 1 h in the dark until ﬂuorescencemeasurement.
DCF ﬂuorescence intensity emission was recorded at 520 nm with
480 nm excitation. Results were expressed as μmol DCF/mg of protein,
using a standard curve with DCF.
NP-SH levels were determined in the cerebral structures of
rats by the method of Ellman [48]. Aliquots from S1 were mixed
(1:1) with 10% trichloroacetic acid (TCA) and centrifuged at 3500 rpm
for 10 min. After centrifugation, an aliquot of supernatant (200 μl)
was added to a reaction medium containing 0.5 mM phosphate buffer
pH 7.4, and 10 mM 5,5′-dithio-bis(2-nitrobenzoic acid) (DTNB).
NP-SH levels were measured at 412 nm, using a standard curve with
reduced glutathione (GSH). Results were expressed as nmol SH/mg of
protein.Table 2
Effects of MTZ and diphenyl diselenide supplementation on locomotor and exploratory
activities in the open-ﬁeld test.
Hypothyroidism induction Groups
Parameters Control MTZ
Crossings 46.1 ± 2.47 44.8 ± 2.86
Rearing 14.5 ± 1.39 16.0 ± 1.85
Parameters Control MTZ Se MTZ + Se
First month of treatment
Crossings 43.0 ± 3.88 44.1 ± 4.28 47.3 ± 4.02 38.5 ± 2.62
Rearing 19.6 ± 2.1 24.2 ± 3.4 18.3 ± 1.85 20.3 ± 2.14
Second month of treatment
Crossings 45.9 ± 3.43 35.1 ± 3.07 41.4 ± 3.6 38.2 ± 1.77
Rearing 13.4 ± 1.69 9.33 ± 1.87 8.0 ± 1.36 8.78 ± 1.08
Third month of treatment
Crossings 29.8 ± 2.71 24.8 ± 3.38 35.6 ± 2.38 28.8 ± 4.69
Rearing 11.6 ± 1.67 10.56 ± 1.38 14.3 ± 1.92 10.2 ± 2.98
Values are expressed as means ± S.E.M of 9–12 rats/group. Crossing and rearing are
expressed as number of times (unpaired T Test/two-way ANOVA followedDuncan's Test).2.7. Monoamine oxidase (MAO) activities
MAOactivitywas determined in total brain as described by Krajl [49]
with modiﬁcations of Matsumoto et al. [50]. Aliquots of samples were
incubated at 37 °C for 5 min in a medium containing Na2HPO4/
KH2PO4 buffer pH 7.4 and speciﬁc inhibitors, selegiline (MAO B inhibi-
tor, 250 ηM) or clorgiline (MAO A inhibitor, 250 ηM), at a ﬁnal volume
of 700 μl. Then kynuramine dihydrobromide was added to the reaction
mixture (ﬁnal concentration, 90 μM to MAO-A and MAO-T assays and
60 μM to MAO-B assay) as substrate. Samples were incubated at 37 °C
for 30 min and reaction was stopped by adding trichloroacetic acid
10%. After centrifugation at 3000 ×g for 15 min, an aliquot of superna-
tant was added to 1 ml 1 M NaOH. The ﬂuorescence intensity was
detected with excitation at 315 nm and emission at 380 nm using a
ﬂuorescence spectrometer. The concentration of 4-hydroxyquinoline
was estimated from a corresponding standard ﬂuorescence curve.
MAO activity was expressed as nmol of 4-hydroxyquinoline/mg of
protein.2.8. Statistical analysis
Datawere analyzed by unpaired T Test and two-wayANOVA followed
by Duncan's Multiple Range Test when appropriated. Data are presented
as mean ± S.E.M. Differences among the groups were considered signif-
icant when p b 0.05.
3. Results
3.1. Thyroid hormones determination
Two-way ANOVA followed by Post Hoc comparisons showed that
MTZ exposure was associated with low tT3 and tT4 plasma levels,
which were not modiﬁed by dietary diphenyl diselenide treatment
(p N 0.05) (Table 1). tT4 levels were lower in the group treated with
diphenyl diselenide alone when compared to the control (p N 0.05).
Statistical analysis also revealed that there was a signiﬁcant
MTZ × Se interaction in both tT3 [F(1,21) = 8.38, p b 0.008] and
tT4 [F(1,20) = 11.27, p b 0.0031] levels. Indeed, a main effect of
Se was veriﬁed on the tT3 [F(1,21) = 25.20, p b 0.0001] and tT4
[F(1,20) = 39.11, p = 0.0002] content.
3.2. Open-ﬁeld task and forced swimming test evaluation
No signiﬁcant statistical difference was observed between control
andMTZ groups in the crossing (unpaired T Test, p = 0.73) and rearing
(unpaired T Test, p = 0.501) numbers before dietary diphenyl
diselenide treatment. These data exclude the motor impairments that
could inﬂuence the behavior of animals in the forced swimming test
(Table 2).
Two-way ANOVA followed by Post Hoc comparisons revealed that
there was no signiﬁcant difference among the groups in the locomotor
and exploratory activities evaluated 1, 2 and 3 months after dietary
diphenyl diselenide treatment (Table 2). No signiﬁcant main effect of
Fig. 2. Effects of MTZ and diphenyl diselenide supplementation on the immobility time in the FST. (A): FST in the period of hypothyroidism induction (30 days). FST in the ﬁrst (B), second
(C) and third (D) month of diphenyl diselenide supplementation after the hypothyroidism induction. Immobility time is expressed in seconds and represents the mean ± S.E.M. of
9–12 rats/group. *p b 0.05 from control group.
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(p N 0.05).
Fig. 2 shows the immobility time of groups during the FST. The data
of Graph A reveal that the administration of MTZ in drinking water for
30 days caused a signiﬁcant increase on the immobility time of animals
when compared to control group (unpaired T Test, p b 0.0001); indicat-
ing that the experimental protocol of hypothyroidismwas able to trigger
a depressive-like behavior in FST.
Graphs B, C and D illustrate the effects of diphenyl diselenide
on depression-like behavior induced by MTZ exposure after 1, 2 and
3 months of supplementation, respectively. Two-way ANOVA followed
by Post Hoc comparisons indicated that MTZ exposed rats had a signif-
icant increase on the immobility time when compared to the control
group in all periods of assessment (p b 0.05). In all periods analyzed,
this effect of MTZ was completely blunted by dietary diphenyl
diselenide (p b 0.05; Graphs B, C and D). A signiﬁcant main effect ofTable 3
Effects of MTZ and diphenyl diselenide supplementation on TBARS, ROS and NP-SH levels
in the cerebral cortex, hippocampus and striatum.
Control MTZ Se MTZ + Se
Cerebral cortex TBARS 0.29 ± 0.04 0.24 ± 0.02 0.24 ± 0.03 0.19 ± 0.01
ROS 7.27 ± 1.08 10.0 ± 3.18 8.98 ± 1.38 7.61 ± 1.52
NP-SH 16.4 ± 1.32 13.1 ± 0.94 15.3 ± 0.87 16.1 ± 1.62
Hippocampus TBARS 0.08 ± 0.02 0.26 ± 0.05⁎ 0.11 ± 0.01 0.17 ± 0.06
ROS 5.52 ± 1.19 10.6 ± 0.93⁎ 6.59 ± 0.69 5.75 ± 1.01
NP-SH 16.0 ± 1.02 12.6 ± 0.63 12.2 ± 0.49 15.44 ± 1.34
Striatum TBARS 0.29 ± 0.03 0.27 ± 0.01 0.36 ± 0.05 0.11 ± 0.03
ROS 26.4 ± 6.32 24.6 ± 6.51 21.6 ± 3.67 21.2 ± 2.4
NP-SH 16.3 ± 1.02 11.9 ± 2.48 14.1 ± 1.86 16.0 ± 1.26
Values are expressed as means ± S.E.M. of 5–6 rats/group. TBARS are expressed as nmol
malondialdehyde/mg of protein; ROS as μmol DCF/mg of protein and NP-SH as nmol
SH/mg of protein.
⁎ Denoted p b 0.05 from control group (two-way ANOVA followed Duncan's Test).Se on immobility time was veriﬁed in the 1st [F(1,44) = 13.68,
p b 0.0006], 2nd [F(1,38) = 4.21, p b 0.04] and 3rd [F(1,44) =
5.54, p b 0.023] month of treatment. Similarly, statistical analysis
revealed a main effect of MTZ in all time periods (1st =
[F(1,44) = 14.91, p b 0.0004]; 2nd = [F(1,38) = 5.29, p b 0.027]
and 3rd = [F(1,44) = 7.84, p b 0.007]) on immobility parameter.
Se × MTZ interaction was not signiﬁcant on immobility time anal-
ysis (p N 0.05).
3.3. Lipid peroxidation, ROS and NP-SH determination
Two-way ANOVA followed by Post Hoc comparisons showed that
MTZ exposure increased TBARS and ROS levels in the hippocampus
when compared to the control group (Table 3). These effects of MTZ
were restored to the control levels by diphenyl diselenide supplementa-
tion (p b 0.05). On the contrary, no statistical difference on lipid perox-
idation and ROS levels in the cerebral cortex and striatum was veriﬁed
among the groups. The NP-SH content was not modiﬁed by MTZ expo-
sure and/or diphenyl diselenide supplementation in any of the cerebral
structures analyzed (Table 3). No signiﬁcant main effect of Se or MTZ
was veriﬁed in these parameters (p N 0.05). However, there was a sig-
niﬁcant interaction between Se and MTZ in hippocampal ROS levels
[F(1,20) = 3.66, p b 0.007].
3.4. MAO activities
Fig. 3 illustrates the MAO activities in total brain. Two-way ANOVA
followed by Post Hoc comparisons revealed that MAO-total and MAO-
A activities were not changed byMTZ exposure and/or dietary diphenyl
diselenide when compared to the control group. Differently, MAO-B
activity was signiﬁcantly decreased in the MTZ group when compared
to the control group (p b 0.05). Dietary diphenyl diselenide was effec-
tive in restoringMAO-B activity to the control levels (p b 0.05). Indeed,
diphenyl diselenide did not modify per se the MAO activities. A
Fig. 3. Effects of MTZ and diphenyl diselenide supplementation onMAO activity. (A)MAO
total activity, (B)MAOA activity and (C)MAOB activity.MAO activities were expressed as
ηmol of 4-hydroxyquinoline formed/mg of protein and represent the mean ± S.E.M. of
5–6 rats/group.*p b 0.05 from control group.
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[F(1,18) = 4.84, p b 0.04] and MAO B [F(1,17) = 7.89, p b 0.01]
activities.4. Discussion
In the current study we have shown that the exposure of female
rats to MTZ induced a depressive-like behavior that was substantially
mitigated by diphenyl diselenide intake. The antidepressive-like effect
associated to dietary diphenyl diselenide was obtained independently
of thyroid hormone levels, which remained lower even in the hypothy-
roid group that received diphenyl diselenide.
The depressive-like behavior evaluation was performed by
the FST that is widely employed as a behavioral tool for screening of an-
tidepressant drugs [44]. The test is based on the observation that ro-
dents, after initial escape-oriented movements, develop an immobileposture when exposed to an inescapable stressful event. In this way,
when some antidepressant drug is administered prior to the test, the
experimental subject will develop an escape-directed behavior for
longer periods of time when compared to the control group. This task
is quite sensitive to all major classes of antidepressant drugs including
tricyclics, serotonin-speciﬁc reuptake inhibitors, monoamine oxidase
inhibitors, and atypicals [51]. We also conducted an evaluation of loco-
motor and exploratory activities by open-ﬁeld test in order to exclude
mismatch factors to the forced swimming test. In this parameter, we
observed that the reduction in the immobility time in the FST elicited
by dietary diphenyl diselenide was not accompanied by alterations on
locomotor activity, demonstrating that the effect exhibited by dietary
diphenyl diselenide cannot be attributable to a psychostimulant action.
Similarly, hypothyroidism condition did not change the locomotor and
exploratory activities that could be harmful to animal performance in
FST.
It is important to mention here that the chronic intake of diphenyl
diselenide supplied diet usually is not associated with common signs
of toxicity as bodyweight loss, hepatotoxicity and/or nephrotoxicity. Ac-
cordingly, previous works of our research group have shown that oral
supplementation with this selenium compound (1–10 ppm) during
similar periods may be considered relatively secure in terms of toxicity
to rats and other species, including rabbits andﬁsh [40–42,52–54]. How-
ever, under our experimental conditions, the animals treated with
diphenyl diselenide alone exhibited T4 levels lower than the control.
In view of the previous ﬁndings, we believe that this effect is due to
the biologic variability found on thyroid status among the groups.
Hypothyroidism is an endocrine dysfunction linked to an increased
susceptibility to depression and reduction in human health-related
quality of life [6–9]. Epidemiological studies have demonstrated that
severe and/or mild hypothyroidism induces depression symptoms
[8,9]. Although, there is evidence on a possible interaction between
monoaminergic systems and hypothalamic–pituitary–thyroid axis
[13,55], the neuropharmacological basis and the functional pathways
for the modulatory effects of thyroid hormones on mood are yet to be
understood.
According to ﬁndings based on humans, experimental hypothyroid-
ism causes depressive-like behavior. Kulikov et al. [37] have demon-
strated that severe hypothyroidism induced by thyroidectomy or mild
hypothyroidism caused by iodine-free diet is able to increase the immo-
bility time of animals in the forced swimming paradigm. In analogy, our
data conﬁrm these results and also show that hypothyroidism triggered
by methimazole exposure may be considered a consistent model to
study this neurological disorder. Furthermore, we showed previously
that hypothyroid female rats develop spatial learning and memory
deﬁcits [40].
The pharmacological properties of diphenyl diselenide are common-
ly linked to its antioxidant potential [25–29]. Nevertheless, there is evi-
dence that antidepressant-like effect mediated by compound involves
the participation of serotoninergic (5-HT1a, 5-HT2a/2c and 5-HT3
receptors), noradrenergic (α1 and α2 receptors) and dopaminergic
(D1, D2 and D3 receptors) systems [21–23]. In terms of mechanisms it
also highlights the role of some types of K+ channels and PPARλ recep-
tors (peroxisome proliferator-activated receptor) and the cerebralMAO
activity modulation [22,56]. Indeed, the antidepressant-like effect of
diphenyl diselenide veriﬁed by Acker et al. [24] on malathion-exposed
rats was related with cerebral cortex Na+–K+–ATPase activity restora-
tion. In our experimental protocol, the antidepressant-like action of
compound observed on hypothyroid rats was followed by a reduction
in hippocampal TBARS and ROS levels. Although we have not deter-
mined other oxidant/antioxidant parameters, it is possible assume
here that the antioxidant activity of diphenyl diselenide had contributed
to diminish the depression symptoms under hypothyroidism condition.
Consistent with this ﬁnding, some studies have demonstrated the efﬁ-
cacy of antioxidant therapies in reducing stress oxidative parameters
in experimental models of hypothyroidism [30–33].
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of oxidative stress andmonoaminergic neurotransmission.MAO is ami-
tochondrial bound enzyme, which catalyzes the oxidative deamination
of dietary amines, monoamine neurotransmitters and hormones. Two
different types of MAO, named A and B, have been characterized on
the basis of substrate and inhibitor sensitivity. MAO A displays a higher
afﬁnity for serotonin and norepinephrine, while MAO B prefers beta-
phenylethylamine [57]. It is has been pointed that MAO B deﬁcient
mice present increased mobility in the FST without signiﬁcant changes
on locomotor patterns in the open-ﬁeld and elevated plus maze tests
[58]. Here, we found a signiﬁcant inhibition of MAO B activity in hypo-
thyroid rats. However, this activity reduced was accompanied by an
increase on immobility time in FST test. Thus, it is possible to suppose
that the inhibition of MAO B under hypothyroidism may reﬂect a com-
pensatory response to oxidative insults and/or depressive behavior. In
fact, the inhibition of MAO B activity could reduce oxidative stress and
redox unbalance by diminishing the hydrogen peroxide formation as
well as modulating mood by increasing the levels of beta-phenylethyl-
amine, which acts as an endogenous amphetamine [58–60].
Taken together, our results show the efﬁcacy of dietary diphenyl
diselenide in declining the depressive-like behavior associated to
methimazole-induced hypothyroidism in female rats. However, addi-
tional studies are necessary to better understand the mechanisms in-
volved in the effects of both diphenyl diselenide and thyroid hormones
on depression symptom development.
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